CBU
NUVB icon

CIBC Bancorp USA’s Nuvation Bio NUVB Stock Holding History

CIBC Bancorp USA’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79K Buy
13,916
+770
+6% +$3.76K ﹤0.01% 1869
2026
Q1 		$56.4K Buy
+13,146
New +$73.2K ﹤0.01% 1715
2025
Q3 		$98.4K Buy
+26,604
New +$72.5K ﹤0.01% 1355

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CIBC Bancorp USA's NUVB Position: Q2 2026 in Review

CIBC Bancorp USA increased its Nuvation Bio (NUVB) stake by 5.9% in Q2 2026, buying an estimated $3.76K and bringing the position to 13,916 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #1869.

CIBC Bancorp USA first reported a position in NUVB in Q3 2025 and has held it in 3 quarters since. The position peaked at $98.4K in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • CIBC Bancorp USA held 13,916 shares of Nuvation Bio worth $79K as of Q2 2026.
  • CIBC Bancorp USA bought 770 Nuvation Bio shares in Q2 2026, an estimated $3.76K.
  • Nuvation Bio made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1869 holding.
  • CIBC Bancorp USA first reported a position in Nuvation Bio in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Nuvation Bio position peaked at $98.4K in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.